Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, May 1, 2015
Pharmacies doing wrong by rejecting certain kinds of customers
Pharmacies doing wrong by rejecting certain kinds of customers
Spartan Daily-13 hours ago
One of the worst examples of profiling was from a story on ABC News which showed how pharmacies are turning away patients and telling them they don't have ...
NACDS: Pharmacy a Key Player in 21st Century Cures Initiative
NACDS: Pharmacy a Key Player in 21st Century Cures Initiative
Pharmacy Times-21 hours ago
“As the face of neighborhood healthcare, retail pharmacies can play an important role in the delivery of new lifesaving drug treatments that result from the 21st ..
Question of the Day May 1, 2015 If compounders were to challenge the DQSA in federal court would legislative intent even be looked at based on language in the statute that was passed? Is a court challenge in the near future? Why hasn't it already been done in light of the 483s issued to compounding pharmacies? Is it because the argument is meritless? Why or why not? Is that the only way to resolve the issue since Congress has not introduced an amend to the DQSA in the manner that compounders and groups that represent them want it to be interpreted? Should Congress reexamine the authority it granted to the FDA? Give it more authority over compounding pharmacies? Less? Why or why not?
Article Claims that The Language Of The DQSA Contradicts Congressional Intent
Law360, New York (May 01, 2015, 9:58 AM ET) -- In 2013, Congress enacted the Drug Quality and Security Act (DQSA), amending the Food, Drug and Cosmetic Act and creating a new category of federally regulated drug compounding establishments called outsourcing facilities.[1] Congress passed the legislation after the New England Compounding Center (NECC) incident in 2012, which left 64 people dead from a meningitis outbreak caused by contaminated mass-compounded sterile injectable drugs.[2]
The primary focus of the DQSA was to give FDA clear jurisdictional authority over mass-compounding pharmacies such as the NECC. One of the reasons...
The primary focus of the DQSA was to give FDA clear jurisdictional authority over mass-compounding pharmacies such as the NECC. One of the reasons...
To view the full article, register now.
Commentary: Compound medications can benefit patients Military Times
Commentary: Compound medications can benefit patients
As a physician and a veteran who works closely withcompounding ... I came home, found a quality compoundingpharmacist that I trusted, and ...
Express Scripts unit to pay $45 million to US over Novartis kickback... Reuters-12 minutes ago
Express Scripts unit to pay $45 million to US over Novartis kickback...
Reuters-12 minutes ago
The settlement with specialty pharmacyAccredo Health Group Inc was disclosed in court papers filed Thursday
McKesson settles investigation on controlled substances Thu Apr 30, 2015 5:29pm EDT
(Reuters) - U.S. drug wholesaler McKesson Corp said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances more
http://mobile.reuters.com/article/idUSKBN0NL2P220150430?irpc=932
Subscribe to:
Posts (Atom)